Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous CIK cells in metastatic colon cancer
NCT03329664Phase 2Unknown
- Sponsor
- Sabz Biomedicals
- Start
- Feb 2020
- Primary completion
- Sep 2021
- Modality
- Allogeneic CAR-T, Tumor-Infiltrating Lymphocytes (TILs), TCR-Engineered T Cells
- Countries
- 1
01
Overview
A Phase 2 trial of unmodified CIK in colorectal cancer (CRC), sponsored by Sabz Biomedicals. Status: unknown.
02
Drugs
unmodified CIK
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT03329664.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03329664.